|
Volumn 53, Issue 1, 2012, Pages 173-175
|
Bone involvement in patients with stage IV diffuse large B-cell lymphoma: Does it have a prognostic value?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
LACTATE DEHYDROGENASE;
PREDNISOLONE;
RITUXIMAB;
VINCRISTINE;
ADULT;
BONE METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INVASION;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CASE CONTROL STUDY;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LARGE CELL LYMPHOMA;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE NEOPLASMS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KAPLAN-MEIER ESTIMATE;
LOWER EXTREMITY;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PELVIC BONES;
PROGNOSIS;
RIBS;
SKULL;
SPINE;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
UPPER EXTREMITY;
|
EID: 84855439868
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.3109/10428194.2011.608452 Document Type: Letter |
Times cited : (11)
|
References (7)
|